VPIM
IPSC icon

Vanguard Personalized Indexing Management’s Century Therapeutics IPSC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,214
Closed -$10.3K – 1883
2024
Q4 		$10.3K Buy
+10,214
New +$13.9K ﹤0.01% 1800

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Personalized Indexing Management's IPSC Position: Q1 2025 in Review

Vanguard Personalized Indexing Management sold out of Century Therapeutics (IPSC) in Q1 2025, closing a stake of 10,214 shares — an estimated $10.3K sold.

Vanguard Personalized Indexing Management first reported a position in IPSC in Q4 2024 and held it in 1 quarter. The position peaked at $10.3K in Q4 2024. 70 funds tracked by Wall St. Rank hold IPSC as of Q1 2025.

  • Vanguard Personalized Indexing Management reported no remaining Century Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 10,214 Century Therapeutics shares in Q1 2025, an estimated $10.3K.
  • Vanguard Personalized Indexing Management first reported a position in Century Therapeutics in Q4 2024 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Century Therapeutics position peaked at $10.3K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2025, filed 14 May 2025.